@article{article, title  = {{EE359 Cost-Effectiveness of Pembrolizumab + Chemotherapy Versus Cetuximab-Containing Regimens ‘Extreme’ and ‘TPEx’, for R/M SCCHN Patients with a CPS between 1 and 19, in Italy}},

 publisher = {{Elsevier BV}},

 url = {{http://dx.doi.org/10.1016/j.jval.2023.09.625 }},

 year = {{2023}},

 month = {{12}},

 author = {{Ivanyi P and Bullement A and Ciccarone A and Schlichting M and Naik J and Colombo GL and Gandola A and Pescott CP}},

 doi = {{10.1016/j.jval.2023.09.625}},

 volume = {{26}},

 journal = {{Value in Health}},

 issue = {{12}},

 pages = {{S120-S120}},

 note = {{Accessed on 2024/12/26}}}